THE EFFECT OF POLYMORPHISM IN GLUTATHIONE S-TRANSFERASES ON THE DEVELOPING SECOND MALIGNANT NEOPLASMS AFTER LEUKEMIA TREATMENT IN CHILDHOOD
<p>Background. Survivors of childhood leukemia have an increased risk of developing second malignant neoplasms and specific treatment factors such as alkylating agents, topoisomerase inhibitors and radiation have been associated with their occurrence. Genetic polymorphism in drug-metabolizing...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Slovenian Medical Association
2004-12-01
|
| Series: | Zdravniški Vestnik |
| Subjects: | |
| Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/2416 |
| _version_ | 1819207988039122944 |
|---|---|
| author | Janez Jazbec Vita Dolžan Maruša Debeljak Richard Aplenc Berta Jereb |
| author_facet | Janez Jazbec Vita Dolžan Maruša Debeljak Richard Aplenc Berta Jereb |
| author_sort | Janez Jazbec |
| collection | DOAJ |
| description | <p>Background. Survivors of childhood leukemia have an increased risk of developing second malignant neoplasms and specific treatment factors such as alkylating agents, topoisomerase inhibitors and radiation have been associated with their occurrence. Genetic polymorphism in drug-metabolizing enzymes may result in impared detoxification of chemotherapeutics and may lead to increased risk for cancer.</p><p>Methods. To test if polymorphism in glutathione S-transferases (GST) genes is associated with occurrence of secondary malignant neoplasms, we compared GSTM1, GSTT1 and GSTP1 genotypes among 16 patients treated for childhood leukemia in whom second neoplasm occurred and matched the control group.</p><p>Results. GSTM1 null genotype was found in 44% of patients with second neoplasms and in 50% in control group (p = 0.768), GSTT1 null genotype in 19% of cases and in 29% of controls (p = 0.729) and GSTP1 105 Ile/ile in 50% of cases and 37% of controls (p = 0.537). Differences in distribution of GST genotypes in patients with second neoplasms after childhood leukemia, compared to a matched control group of patients were not statistically significant.</p><p>Conclusions. In our study we were not able to show relation between GST genotype and occurrence of second neoplasms after the childhood acute leukemia.<br /><br /></p> |
| first_indexed | 2024-12-23T05:32:14Z |
| format | Article |
| id | doaj.art-62a3cc1e075542a39e57db45d39910c0 |
| institution | Directory Open Access Journal |
| issn | 1318-0347 1581-0224 |
| language | English |
| last_indexed | 2024-12-23T05:32:14Z |
| publishDate | 2004-12-01 |
| publisher | Slovenian Medical Association |
| record_format | Article |
| series | Zdravniški Vestnik |
| spelling | doaj.art-62a3cc1e075542a39e57db45d39910c02022-12-21T17:58:27ZengSlovenian Medical AssociationZdravniški Vestnik1318-03471581-02242004-12-017301885THE EFFECT OF POLYMORPHISM IN GLUTATHIONE S-TRANSFERASES ON THE DEVELOPING SECOND MALIGNANT NEOPLASMS AFTER LEUKEMIA TREATMENT IN CHILDHOODJanez Jazbec0Vita Dolžan1Maruša Debeljak2Richard Aplenc3Berta Jereb4Služba za onkologijo in hematologijo Pediatrična klinika Klinični Center Vrazov trg 1 1525 LjubljanaInštitut za biokemijo Medicinska fakulteta v Ljubljani Vrazov trg 2 1000 LjubljanaSlužba za onkologijo in hematologijo Pediatrična klinika Klinični Center Vrazov trg 1 1525 LjubljanaChildren’s Hospital of Philadelphia 34th Street Philadelphia USAOnkološki inštitut Ljubljana Zaloška 2 1000 Ljubljana<p>Background. Survivors of childhood leukemia have an increased risk of developing second malignant neoplasms and specific treatment factors such as alkylating agents, topoisomerase inhibitors and radiation have been associated with their occurrence. Genetic polymorphism in drug-metabolizing enzymes may result in impared detoxification of chemotherapeutics and may lead to increased risk for cancer.</p><p>Methods. To test if polymorphism in glutathione S-transferases (GST) genes is associated with occurrence of secondary malignant neoplasms, we compared GSTM1, GSTT1 and GSTP1 genotypes among 16 patients treated for childhood leukemia in whom second neoplasm occurred and matched the control group.</p><p>Results. GSTM1 null genotype was found in 44% of patients with second neoplasms and in 50% in control group (p = 0.768), GSTT1 null genotype in 19% of cases and in 29% of controls (p = 0.729) and GSTP1 105 Ile/ile in 50% of cases and 37% of controls (p = 0.537). Differences in distribution of GST genotypes in patients with second neoplasms after childhood leukemia, compared to a matched control group of patients were not statistically significant.</p><p>Conclusions. In our study we were not able to show relation between GST genotype and occurrence of second neoplasms after the childhood acute leukemia.<br /><br /></p>http://vestnik.szd.si/index.php/ZdravVest/article/view/2416gluthatione S-transferasechildhood leukemiasecondary neoplasm |
| spellingShingle | Janez Jazbec Vita Dolžan Maruša Debeljak Richard Aplenc Berta Jereb THE EFFECT OF POLYMORPHISM IN GLUTATHIONE S-TRANSFERASES ON THE DEVELOPING SECOND MALIGNANT NEOPLASMS AFTER LEUKEMIA TREATMENT IN CHILDHOOD Zdravniški Vestnik gluthatione S-transferase childhood leukemia secondary neoplasm |
| title | THE EFFECT OF POLYMORPHISM IN GLUTATHIONE S-TRANSFERASES ON THE DEVELOPING SECOND MALIGNANT NEOPLASMS AFTER LEUKEMIA TREATMENT IN CHILDHOOD |
| title_full | THE EFFECT OF POLYMORPHISM IN GLUTATHIONE S-TRANSFERASES ON THE DEVELOPING SECOND MALIGNANT NEOPLASMS AFTER LEUKEMIA TREATMENT IN CHILDHOOD |
| title_fullStr | THE EFFECT OF POLYMORPHISM IN GLUTATHIONE S-TRANSFERASES ON THE DEVELOPING SECOND MALIGNANT NEOPLASMS AFTER LEUKEMIA TREATMENT IN CHILDHOOD |
| title_full_unstemmed | THE EFFECT OF POLYMORPHISM IN GLUTATHIONE S-TRANSFERASES ON THE DEVELOPING SECOND MALIGNANT NEOPLASMS AFTER LEUKEMIA TREATMENT IN CHILDHOOD |
| title_short | THE EFFECT OF POLYMORPHISM IN GLUTATHIONE S-TRANSFERASES ON THE DEVELOPING SECOND MALIGNANT NEOPLASMS AFTER LEUKEMIA TREATMENT IN CHILDHOOD |
| title_sort | effect of polymorphism in glutathione s transferases on the developing second malignant neoplasms after leukemia treatment in childhood |
| topic | gluthatione S-transferase childhood leukemia secondary neoplasm |
| url | http://vestnik.szd.si/index.php/ZdravVest/article/view/2416 |
| work_keys_str_mv | AT janezjazbec theeffectofpolymorphisminglutathionestransferasesonthedevelopingsecondmalignantneoplasmsafterleukemiatreatmentinchildhood AT vitadolzan theeffectofpolymorphisminglutathionestransferasesonthedevelopingsecondmalignantneoplasmsafterleukemiatreatmentinchildhood AT marusadebeljak theeffectofpolymorphisminglutathionestransferasesonthedevelopingsecondmalignantneoplasmsafterleukemiatreatmentinchildhood AT richardaplenc theeffectofpolymorphisminglutathionestransferasesonthedevelopingsecondmalignantneoplasmsafterleukemiatreatmentinchildhood AT bertajereb theeffectofpolymorphisminglutathionestransferasesonthedevelopingsecondmalignantneoplasmsafterleukemiatreatmentinchildhood AT janezjazbec effectofpolymorphisminglutathionestransferasesonthedevelopingsecondmalignantneoplasmsafterleukemiatreatmentinchildhood AT vitadolzan effectofpolymorphisminglutathionestransferasesonthedevelopingsecondmalignantneoplasmsafterleukemiatreatmentinchildhood AT marusadebeljak effectofpolymorphisminglutathionestransferasesonthedevelopingsecondmalignantneoplasmsafterleukemiatreatmentinchildhood AT richardaplenc effectofpolymorphisminglutathionestransferasesonthedevelopingsecondmalignantneoplasmsafterleukemiatreatmentinchildhood AT bertajereb effectofpolymorphisminglutathionestransferasesonthedevelopingsecondmalignantneoplasmsafterleukemiatreatmentinchildhood |